A2B adenosine receptor antagonists: Recent developments

Mini-Reviews in Medicinal Chemistry

Volumn 5, Issue 12, 2005, Pages 1053-1060

  Cacciari, Barbara ^a   Pastorin, Giorgia ^b   Bolcato, Chiara ^b   Spalluto, Giampiero ^a,b   Bacilieri, Magdalena ^c   Moro, Stefano ^c  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 PROPYL 8 (4 SULFOPHENYL)XANTHINE; 2 (7 METHOXY 4 METHYLQUINAZOLIN 2 YLAMINO) 4,5 DIHYDRO 3H IMIDAZOL 4 ONE; 4 AMINOBUTYRIC ACID; 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 5 TERT BUTYLOXYCARBONYL DERIVATIVE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 9 CHLORO 2 (2 FURYL) 5,6 DIHYDRO 5 IMINO 1,2,4 TRIAZOLO[2,3 C]QUINAZOLINE; ADENINE DERIVATIVE; ADENOSINE A2B RECEPTOR; ADENOSINE A2B RECEPTOR ANTAGONIST; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; ADENYLATE CYCLASE; CMB 6446; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; LUF 5451; LUF 5452; MESSENGER RNA; MRS 1224; MRS 1706; N (4 CYANOPHENYL) 2 [4 (2,3,6,7 TETRAHYDRO 2,6 DIOXO 1,3 DIPROPYL 1H PURIN 8 YL)PHENOXY]ACETAMIDE; N BENZO[1,3]DIOXOL 5 YL 2 [5 (2,6 DIOXO 1,3 DIPROPYL 2,3,6,7 TETRAHYDRO 1H PURIN 8 YL) 1 METHYL 1H PYRAZOL 3 YLOXYL]ACETAMIDE; PROTEIN KINASE C; PSB 1115; PYRIMIDINE DERIVATIVE; QUINAZOLINE DERIVATIVE; TRIAZINE DERIVATIVE; TRIAZOLOQUINAZOLINE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN; XANTHINE DERIVATIVE; [[N (4 ACETYLPHENYL) 2 [4 (2,3,6,7 TETRAHYDRO 2,6 DIOXO 1,3 DIPROPYL 1H PURIN 8 YL)]PHENOXYL]ACETAMIDE]; [[N (4 CYANOPHENYL) 2 [4 (2,3,6,7 TETRAHYDRO 2,6 DIOXO 1,3 DIPROPYL 1H PURIN 8 YL)]PHENOXYL]ACETAMIDE]; ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT; TRIAZOLE DERIVATIVE;

AMINO ACID SEQUENCE; ANTIINFLAMMATORY ACTIVITY; ASTHMA; DRUG IDENTIFICATION; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; ENZYME ACTIVE SITE; GENE MUTATION; HUMAN; LIGAND BINDING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SEQUENCE ANALYSIS; STRUCTURE ACTIVITY RELATION; ANIMAL; BINDING SITE; CHEMISTRY; DRUG ANTAGONISM; DRUG DESIGN; METABOLISM; MOLECULAR GENETICS; PATHOLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BINDING SITES; DRUG DESIGN; HUMANS; MOLECULAR SEQUENCE DATA; QUINAZOLINES; RECEPTOR, ADENOSINE A2B; TRIAZOLES; XANTHINES;

EID: 28444492060     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955705774933374     Document Type: Review

References (58)

1. Fredholm, B.B.; Ijzerman, A.P.; Jacobson, K.A.; Klotz, K.N.; Linden, J. Pharmacol. Rev. 2001, 53, 527.
2. Kostopoulos, G.K. In Neurotransmitters and cortical function: from molecules to mind, Avoli, M.; Reader, T.A.; Dykes, R.W. and Gloor, P. Eds. pp. 415-435. Plenum Press, New York, 1988.
3. Burnstock, G. In Cell Membrane Receptors for Drugs and Hormones, Bolis, L. and Straub, R.W. eds pp. 107-118, Raven Press, New York, 1978.
4. Van Calker, D.; Müller, M.; Hamprecht, B. J. Neurochem., 1979, 33, 999.
5. Londos, C.; Cooper, D.M.F.; Wolff, J. Proc. Natl. Acad. Sci. USA, 1980, 77, 2551.
6. Daly, J.W.; Butts-Lamb, P.; Padgett, W. Cell. Mol. Neurobiol., 1983, 3, 69.
7. Bruns, R.F.; Lu, G.H.; Pugsley, T.A. Mol. Pharmacol., 1986, 29, 331.
8. Fredholm, B.B.; Burnstock, G.; Harden, T.K.; Spedding, M. Drug Dev. Res., 1996, 39, 461.
9. Fredholm, B.B.; Abbracchio, M.P.; Burnstock, G.; Dubyak, G.R.; Harden, T.K.; Jacobson, K.A.; Schwabe, U.; Williams, M. Trends Pharmacol. Sci., 1997, 18, 79.
10. Arslan, G.; Kull, B.; Fredholm, B.B. Naunyn-Schmiedeberg's Arch. Pharmacol., 1999, 359, 28.
11. Kessey, K.; Trommer, B.L.; Overstreet, L.S.; Ji, T. Mogul, D.J. Brain Res., 1997, 756, 184.
12. Peakman, M.C.; Hill, S.J. Br. J. Pharmacol., 1994, 111, 191.
13. Brackett, L.E.; Daly, J.W. Biochem. Pharmacol., 1994, 47, 801.
14. Dubey, R.K.; Gillespie, D.G.; Osaka, K.; Suzuki, F.; Jackson, E.K. Hipertension, 1996, 27, 786.
15. Feoktistov, I.; Biaggioni, I. Mol. Pharmacol., 1993, 43, 909.
16. Feoktistov, I.; Biaggioni, I. J. Clin. Invest., 1995, 96, 1979.
17. Liang, B.T.; Haltiwanger, B. Circ. Res., 1995, 76, 242.
18. Nicholls, J.; Brownhill, V.R.; Hourani, S.M.O. Br. J. Pharmacol., 1996, 117, 170.
19. Iwamoto, T.; Umemura, S.; Toya, Y.; Uchibori, T.; Kogi, K.; Takagi, N.; Ishii, M. Biochem. Biophys. Res. Commun., 1994, 199, 905.
20. Feoktistov, I.; Biaggioni, I. Pharmacol. Rev., 1997, 49, 381.
21. Mogul, D.J.; Adams, M.E.; Fox, A.P. Neuron, 1993, 10, 327.
22. Yakel, J.L.; Warren, R.A.; Reppert, S.M.; North, R.A. Mol. Pharmacol., 1993, 43, 277.
23. Altiok, N.; Balmforth, A.J.; Fredholm, B.B. Acta Physiol. Scand., 1992, 144, 55.
24. Altiok, N.; Fredholm, B.B. Cell. Signalling, 1993, 5, 279.
25. Phillis, J.W.; O'Regan, M.H.; Perkins, L.M. Brain Res., 1993, 605, 293.
26. Webb, R.L.; Sillis, M.A.; Chovan, J.P.; Balwierczak, J.L.; Francis, J.E. Cardiovasc. Drug Rev., 1992, 10, 26.
27. Feoktistov, I.; Polosa, R.; Holgate, S.T.; Biaggioni, I. Trends Pharmacol. Sci., 1998, 19, 148.
28. Murthy, K.S.; Mchenry, L.; Grider, J.R.; Makhlouf, G.M. J. Pharmacol. Exp. Ther., 1995, 274, 300.
29. Vallejo, A.I.; Arin, R.M.; Schijvarger, S.A.; Varela, A. Drug Dev. Res., 2000, 50, 87.
30. Forsythe, P.; Ennis, M. Inflamm. Res., 1999, 48, 301.
31. Feoktistov, I.; Goldstein, A.E.; Biaggioni, I. Drug Dev. Res., 2000, 50, 83.
32. Volpini, R.; Costanzi, S.; Vittori, S.: Cristalli, G.; Klotz, K.N. Curr. Top. Med. Chem., 2003, 3, 427
33. Kim, S.A., Marshall, M.A.; Melman, N.; Kim, H.S.; Muller, C.E.; Linden, J.; Jacobson, K.A. J. Med. Chem., 2002, 45, 2131
34. Hayallah, A.M.; Sandoval-ramirez, J.; Reith, U.; Schobert, U.; Preiss, B.; Schumacher, B.; Daly, J.W.; Muller, C.E. J. Med. Chem., 2002, 45, 1500.
35. Jacobson, K.A.; Ijzerman, A.P.; Linden, J. Drug Dev. Res., 1999, 47, 45.
36. Yan, L.; Muller C.E. J. Med. Chem., 2004, 47, 1031.
37. Kim, Y.C.; Karton, Y.; Ji, X.D.; Melman, N.; Linden, J.; Jacobson, K.A. Drug Dev. Res., 1999, 47, 178.
38. Kim, Y.C.; Ji X.D.; Melman, N.; Linden, J.; Jacobson K.A. J. Med. Chem., 2000, 43, 1165.
39. Ji, X.D.; Kim, Y.C.; Ahern, D.G.; Linden, J.; Jacobson, K.A. Biochem. Pharmacol., 2001, 61, 657
40. Baraldi, P.G.; Tabrizi, M.A.; Preti, D.; Bovero, A.; Romagnoli, R.; Fruttarolo, F.; Zaid, N.A.; Moorman, A.R.; Varani, K.; Gessi, S.; Merighi, S.; Borea, P.A. J. Med. Chem., 2004, 47, 1434.
41. Baraldi, P.G.; Tabrizi, M.A.; Preti, D.; Bovero, A.; Romagnoli, R.; Fruttarolo, F.; Moorman, A.R.; Gessi, S.; Merighi, S.; Varani, K.; Borea, P.A. Bioorg. Med. Chem. Lett., 2004, 14, 3607.
42. Zablocki, J.; Kalla, R.; Perry, T.; Venkata, P.; Varkhendar, V.; Xiao, D.; Piscopio, A.; Man, T.; Gimbel, A.; Hao, J.; Chu, N.; Leung, K.; Zeng, D. Bioorg. Med. Chem. Lett., 2005, 15, 609.
43. Carotti, A.; Stefanachi, A.; Ravina, E.; Sotelo, E.; Loza, M.I.; Cadavid, M.I.; Centeno, N.B.; Nicolotti, O. Eur. J. Med. Chem., 2004, 39, 879.
44. Kim, Y.C.; de Zwart, M.; Chang, L.; Moro, S.; Jacobien, K.; Frijtag, D.K.; Melman, N.; IJzerman, A.P.; Jacobson, K.A. J. Med. Chem., 1998, 41, 2835.
45. Baraldi, P.G.; Cacciari, B.; Romagnoli, R.; Klotz, K.N.; Spalluto, G.; Varani, K.; Gessi, S.; Merighi, S.; Borea, P.A. Drug Dev. Res., 2001, 53, 225.
46. Pastorin, G.; Da Ros, T.; Spalluto, G.; Deflorian, F.; Moro, S.; Cacciari, B.; Baraldi, P.G.; Varani, K.; Gessi, S.; Borea, P.A. J. Med. Chem., 2003, 46, 4287.
47. Ji, X.D.; Jacobson, K.A. Drug Des. Discov., 1999, 16, 217.
48. deZwart, M.; Vollinga, R.C.; Beukers, M.W.; Sleegers, D.F.; von Frijtag Drabbe Kunzel, J.K.; de Groote, M.; Ijzerman, A.P. Drug Dev. Res., 1999, 48, 95.
49. Camaioni, E.; Costanzi, S.; Vittori, S.; Volpini, R.; Klotz, K.N.; Cristalli, G. Bioorg. Med. Chem., 1998, 6, 523.
50. Lambertucci, K.; Camaioni, E.; Costanzi, S.; Kachler, S.; Klotz, K.N.; Volpini, R.; Cristalli, G.; Vittori, S. Drug Dev. Res., 2000, 50, 67.
51. Webb, T.R.; Lvovskiy, D.; Kim, S.-A.; Ji, X.-D.; Melman, N.; Linden, J.; Jacobson, K.A. Bioorg. Med. Chem., 2003, 11, 77.
52. Rivkees, S.A.; Reppert, S.M. Mol. Endocrinol., 1992, 6, 1598.
53. Marquardt, D.L.; Walker, L.L.; Heinemann, S. J. Immunol., 1994, 152, 4508.
54. Moro, S.; Deflorian, F.; Spalluto, G.; Pastorin, G.; Cacciari, B.; Kim, S.K.; Jacobson, K.A. Chem. Commun (Camb)., 2003, 2949.
55. Moro, S.; Braiuca, P.; Deflorian, F.; Ferrari, C.; Pastorin, G.; Cacciari, B.; Baraldi, P.G.; Varani, K.; Borea, P.A.; Spalluto, G. J. Med. Chem., 2005, 48, 152.
56. Moro, S.; Spalluto, G.; jacobson, K.A. Trends Pharmacol. Sci., 2005, 26, 44.
57. Jiang, Q.; Lee, B. X.; Glashofer, M.; van Rhee, A. M.; Jacobson, K. A. J. Med. Chem, 1997, 40, 2588.
58. Gao, Z. G.; Chen, A.; Barak, D.; Kim, S. K.; Muller, C. E.; Jacobson, K.A. J. Biol. Chem., 2002, 277, 19056.